RxDoctor Payments Data

Clyde Wong, MD

Family Medicine · Stockton, CANPI 1487686473

Payments from drug & device makers

$12,033in general payments, 2019–2025

Across 695 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Boehringer Ingelheim$1K
  • AstraZeneca$913
  • GSK$876
  • Lilly USA, LLC$783
  • Johnson & Johnson$739
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$11,998100%
  • Education$180%
  • Entertainment$170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk77$1,313
Boehringer Ingelheim55$1,027
AstraZeneca44$913
GSK59$876
Lilly USA, LLC50$783
Johnson & Johnson59$739
AbbVie(2 entities)43$686
Merck28$488
Amgen(2 entities)22$435
Pfizer20$378
Otsuka America Pharmaceutical, Inc.17$331
Exact Sciences12$266
Bayer14$266
Vanda Pharmaceuticals Inc.13$242
Sanofi-aventis U.S. LLC13$207
Astellas Pharma US Inc10$184
Hologic Sales And Service, LLC8$169
Novartis10$160
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$156
Baxter Healthcare7$145
Phathom Pharmaceuticals, Inc.6$130
Takeda Pharmaceuticals U.S.A., Inc.7$124
Aimmune Therapeutics, Inc.4$120
Sunovion Pharmaceuticals Inc.12$108
Biohaven Pharmaceuticals, Inc.6$102
Teva Pharmaceuticals USA, Inc.6$98
Lundbeck LLC4$89
Eisai Inc.4$88
Sumitomo Pharma America, Inc.4$80
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$78
Philips North America LLC4$78
Electromed, Inc.4$69
Amarin Pharma, Inc.4$68
Idorsia Pharmaceuticals US Inc4$60
Mylan Specialty L.p.3$56
Nabriva Therapeutics, PLC4$55
Arbor Pharmaceuticals, Inc.2$55
Abbott2$49
Biohaven Pharmaceutical Holding Company Ltd.3$47
Ironwood Pharmaceuticals, Inc3$45
Nestle Healthcare Nutrition Inc.2$43
Advanced Respiratory, Inc2$39
Mayne Pharma Commercial LLC2$38
Sanofi Pasteur Inc.2$36
Viatris Specialty LLC2$35
Corcept Therapeutics2$34
Kowa Pharmaceuticals America, Inc.2$34
Boston Scientific1$29
Mannkind Corporation2$28
Intra-sana Laboratories1$26
Kyowa Kirin, Inc.1$26
Organogenesis Inc.1$25
Hikma Pharmaceuticals USA2$24
Azurity Pharmaceuticals, Inc.1$23
Sanofi1$22
Supernus Pharmaceuticals, Inc.1$22
Covis Pharma GmbH1$20
Biogen1$18
Optos, Inc.1$17
Alfasigma USA, Inc.1$17

How this compares

$12,033 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$48,509
Medicare patients
80
Services billed
452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium68$828
Levothyroxine Sodium56$624
Metformin Hcl47$393
Lisinopril20$209
Simvastatin29$208
Allopurinol11$83
Losartan Potassium13$83
Amlodipine Besylate16$53

Paid to pharmacies, not to this prescriber.

Other family medicine in Stockton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →